Faculté de Médecine

Publications (75)

• Article: [Is cholecystokinin a biological support in panic attacks?].

  M Bourin, J Bradwejn, D Koszycki
  L Encéphale 17(5):475-9. · 0.63 Impact Factor
• Article: Clinical Testing of Anxiolytic Drugs

  M. Bourin
• Article: [Software modeling for better understanding of pharmacokinetic-pharmacodynamic relationships: application to azithromycin in the treatment of streptococcal tonsillitis and in acute exacerbation fo chronic bronchitis]].

  Yves le Normand, Henri Drugeon, Sarah Abbas, Brigitte Palestro
  Thérapie 59(1):155-62. · 0.30 Impact Factor
• Article: A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations.

  B Cherrier, F Gouin, M-F Heymann, J P Thiéry, F Rédini, D Heymann, F Duteille
  Tumor Biology 26(3):121-30. · 1.94 Impact Factor
• Article: [Neurotoxicity of ketamine and midazolam by intrathecal injection in the rabbit].

  J M Malinovsky, J M Mussini, A Cozian, J Y Lepage, P Cavaillé, M Pinaud, C de Dieuleveult, R Souron
  Annales Françaises d Anesthésie et de Réanimation 02/1989; 8 Suppl:R174. · 0.84 Impact Factor
• Article: [Clinical and neurobiological aspects of long-term administration of psychotropic drugs].

  M Bourin, J Bradwejn
  Canadian journal of psychiatry. Revue canadienne de psychiatrie 06/1991; 36(4):260-4. · 2.42 Impact Factor
• Article: Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones

  M. Gregoire, L. Garrigue, H. M. Blottiere, M. G. Denis, K. Meflah
  Invasion and Metastasis 02/1992; 12(3-4):185-96.
• Article: [From inducers of panic attack to neurobiology of panic disorder].

  M Bourin
  L Encéphale 01/1997; 22 Spec No 5:35-41. · 0.63 Impact Factor
• Article: Cholecystokinin as a target for neuropsychiatric drugs.

  M Bourin
  Drug News & Perspectives 09/1998; 11(6):342-9. · 2.21 Impact Factor
• Source

  Available from: Dominique Heymann

  Article: gp130 Cytokine family and bone cells.

  D Heymann, A V Rousselle
  Cytokine 11/2000; 12(10):1455-68. · 3.02 Impact Factor
• Article: Drug mechanisms in anxiety.

  M Bourin, M Hascoët
  Current opinion in investigational drugs (London, England: 2000) 03/2001; 2(2):259-65. · 3.31 Impact Factor
• Article: Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice.

  M Bourin, Nic Dhonnchadha BA, M Claude Colombel, M Dib, M Hascoët
  Behavioural Brain Research 10/2001; 124(1):87-95. · 3.42 Impact Factor
• Article: Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders.

  Eva Grimaud, Dominique Heymann, Françoise Rédini
  Cytokine & Growth Factor Reviews 07/2002; 13(3):241-57. · 7.81 Impact Factor
• Source

  Available from: Cedric Jacqueline

  Article: Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.

  Eric Batard, Cedric Jacqueline, David Boutoille, Antoine Hamel, Henri B Drugeon, Nathalie Asseray, Roland Leclercq, Jocelyne Caillon, Gilles Potel, Denis Bugnon
  Antimicrobial Agents and Chemotherapy 07/2002; 46(7):2174-8. · 4.84 Impact Factor
• Source

  Available from: Sébastien Küry

  Article: Identification of SLC39A4, a gene involved in acrodermatitis enteropathica.

  Sébastien Küry, Brigitte Dréno, Stéphane Bézieau, Stéphanie Giraudet, Monia Kharfi, Ridha Kamoun, Jean-Paul Moisan
  Nature Genetics 08/2002; 31(3):239-40. · 35.53 Impact Factor
• Article: Nicotinic receptors and Alzheimer's disease.

  Michel Bourin, Nadège Ripoll, Eric Dailly
  Current Medical Research and Opinion 02/2003; 19(3):169-77. · 2.38 Impact Factor
• Source

  Available from: Michel Bourin

  Article: The mouse light/dark box test.

  Michel Bourin, Martine Hascoët
  European Journal of Pharmacology 03/2003; 463(1-3):55-65. · 2.52 Impact Factor
• Article: Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.

  Michel Bourin
  Human Psychopharmacology Clinical and Experimental 05/2003; 18(3):185-90. · 2.48 Impact Factor
• Source

  Available from: Sébastien Küry

  Article: Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica.

  Sébastien Küry, Monia Kharfi, Ridha Kamoun, Alain Taïeb, Eric Mallet, Jean-Jacques Baudon, Catherine Glastre, Bruno Michel, Francis Sebag, David Brooks, Volker Schuster, Catherine Scoul, Brigitte Dréno, Stéphane Bézieau, Jean-Paul Moisan
  Human Mutation 10/2003; 22(4):337-8. · 5.69 Impact Factor
• Article: [Antibiotic therapy: from pharmacology to decision making].

  Gilles Potel, Jocelyne Caillon, Denis Bugnon
  La Revue du praticien 10/2003; 53(14):1554-60.
• Article: Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.

  Michel Bourin, Eric Dailly, Martine Hascöet
  CNS Drug Reviews 02/2004; 10(3):219-29. · 4.92 Impact Factor
• Article: Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

  Michel Bourin, Elisabeth Mocaër, Roger Porsolt
  Journal of psychiatry & neuroscience: JPN 04/2004; 29(2):126-33. · 5.34 Impact Factor
• Article: Nicotinic receptors and schizophrenia.

  Nadège Ripoll, Marie Bronnec, Michel Bourin
  Current Medical Research and Opinion 08/2004; 20(7):1057-74. · 2.38 Impact Factor
• Source

  Available from: Dominique Heymann

  Article: Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.

  S Théoleyre, K Mori, B Cherrier, N Passuti, F Gouin, F Rédini, D Heymann
  BMC Cancer 02/2005; 5:123. · 3.01 Impact Factor
• Article: Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.

  Barbara Simon-Kayser, Catherine Scoul, Karine Renaudin, Pascal Jezequel, Olivier Bouchot, Jérôme Rigaud, Stéphane Bezieau
  Genes Chromosomes and Cancer 06/2005; 43(1):83-94. · 3.31 Impact Factor
• Article: Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.

  Michel Bourin, Fabienne Masse, Eric Dailly, Martine Hascoët
  Pharmacology Biochemistry and Behavior 08/2005; 81(3):645-56. · 2.53 Impact Factor
• Article: Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test.

  Michel Bourin, Fabienne Masse, Martine Hascoët
  Journal of psychiatry & neuroscience: JPN 08/2005; 30(4):275-82. · 5.34 Impact Factor
• Article: A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.

  Michel Bourin, Franck Chenu, Nadège Ripoll, Denis Joseph Paul David
  Behavioural Brain Research 12/2005; 164(2):266-9. · 3.42 Impact Factor
• Source

  Available from: Dominique Heymann

  Article: Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice.

  Benjamin Ory, Marie-Françoise Heymann, Akira Kamijo, François Gouin, Dominique Heymann, Françoise Redini
  Cancer 01/2006; 104(11):2522-9. · 4.77 Impact Factor
• Article: RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.

  Yohann Wittrant, François Lamoureux, Kanji Mori, Anne Riet, Akira Kamijo, Dominique Heymann, Françoise Redini
  International Journal of Oncology 02/2006; 28(1):261-9. · 2.40 Impact Factor
• Article: [Pharmacology of antipsychotic drugs]].

  M Bourin
  L Encéphale 02/2006; 32 Pt 2:S8-9. · 0.63 Impact Factor
• Article: Osteosarcoma: current status of immunotherapy and future trends (Review).

  Kanji Mori, Françoise Rédini, François Gouin, Bertrand Cherrier, Dominique Heymann
  Oncology Reports 04/2006; 15(3):693-700. · 1.84 Impact Factor
• Article: The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.

  Michel Bourin, Corina Prica
  Neuroscience & Biobehavioral Reviews 02/2007; 31(6):963-75. · 8.65 Impact Factor
• Article: Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.

  François Lamoureux, Valérie Trichet, Céline Chipoy, Frédéric Blanchard, François Gouin, Françoise Redini
  Expert Review of Anti-infective Therapy 03/2007; 7(2):169-81. · 2.65 Impact Factor
• Source

  Available from: Lisa Oliver

  Article: TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax.

  G Bellot, P-F Cartron, E Er, L Oliver, P Juin, L C Armstrong, P Bornstein, K Mihara, S Manon, F M Vallette
  Cell Death and Differentiation 05/2007; 14(4):785-94. · 8.85 Impact Factor
• Article: [Sleep and wakefulness drugs and their indications].

  M Bourin
  Annales Pharmaceutiques Françaises 08/2007; 65(4):251-7.
• Article: Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood-brain barrier.

  Pascale Jolliet, Stéphane Nion, Gwenaëlle Allain-Veyrac, L Tilloy-Fenart, Dorothée Vanuxeem, Vincent Berezowski, Roméo Cecchelli
  Pharmacological Research 08/2007; 56(1):11-7. · 4.44 Impact Factor
• Article: Immune responses to gene product of inducible promoters.

  Caroline Le Guiner, Knut Stieger, Richard O Snyder, Fabienne Rolling, Philippe Moullier
  Current Gene Therapy 11/2007; 7(5):334-46. · 3.39 Impact Factor
• Article: Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.

  Anne Jarry, Céline Bossard, Chantal Bou-Hanna, Damien Masson, Eric Espaze, Marc G Denis, Christian L Laboisse
  Journal of Clinical Investigation 04/2008; 118(3):1132-42. · 15.39 Impact Factor
• Article: Perineal pain and inferior cluneal nerves: anatomy and surgery.

  B Darnis, R Robert, J J Labat, T Riant, C Gaudin, A Hamel, O Hamel
  Surgical and Radiologic Anatomy 06/2008; 30(3):177-83. · 1.06 Impact Factor
• Article: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle.

  Alice Toromanoff, Yan Chérel, Mickaël Guilbaud, Magalie Penaud-Budloo, Richard O Snyder, Mark E Haskins, Jack-Yves Deschamps, Lydie Guigand, Guillaume Podevin, Valder R Arruda, Katherine A High, Hansell H Stedman, Fabienne Rolling, Ignacio Anegon, Philippe Moullier, Caroline Le Guiner
  Molecular Therapy 08/2008; 16(7):1291-9. · 6.87 Impact Factor
• Article: RANKL/RANK/OPG: key therapeutic target in bone oncology.

  Kosei Ando, Kanji Mori, Francoise Rédini, Dominique Heymann
  Current Drug Discovery Technologies 09/2008; 5(3):263-8.
• Article: Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

  Franck Chenu, Denis J P David, Isabelle Leroux-Nicollet, Erwan Le Maître, Alain M Gardier, Michel Bourin
  Journal of psychiatry & neuroscience: JPN 12/2008; 33(6):541-50. · 5.34 Impact Factor
• Source

  Available from: Cedric Jacqueline

  Article: Intermittent active motion versus immobilization in the treatment of Staphylococcus aureus-induced arthritis in a rabbit model.

  Antoine Hamel, Jocelyne Caillon, Cédric Jacqueline, Eric Batard, David Boutoille, Denis Bugnon, Anne-Françoise Miégeville, Jean-Michel Rogez, Gilles Potel
  Journal of Children s Orthopaedics 01/2009; 2(6):491-5.
• Article: The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.

  B Cariou
  Diabetes & Metabolism 01/2009; 34(6 Pt 2):685-91. · 2.41 Impact Factor
• Article: Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.

  Michel Bourin, Corina Prica
  Current pharmaceutical design 02/2009; 15(14):1675-82. · 4.41 Impact Factor
• Article: In situ evidence of involvement of Schwann cells in ulcerative colitis: autocrine and paracrine signaling by A disintegrin and metalloprotease-17-mediated tumor necrosis factor alpha production.

  Jean-François Mosnier, Anne Jarry, Jean-Philippe Camdessanché, Jean-Christophe Antoine, Christian L Laboisse
  Human pathology 05/2009; 40(8):1159-67. · 3.03 Impact Factor
• Article: FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin.

  D Boutoille, X Marechal, Marie Pichenot, C Chemani, B Guery, K Faure
  Experimental Lung Research 05/2009; 35(4):263-71. · 1.22 Impact Factor
• Article: [Cell therapy for acute myocardial infarction].

  P Lemarchand
  Transfusion Clinique et Biologique 06/2009; 16(2):146-7. · 0.80 Impact Factor
• Article: Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

  Michel Bourin, Franck Chenu, Corina Prica, Martine Hascoët
  Psychopharmacologia 07/2009; 206(1):97-107. · 4.08 Impact Factor